FARMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 108,627 | 97,845 | 95,450 | 118,277 | 141,801 | 167,832 | 168,752 | 158,287 |
| Profit before tax | 10,614 | 4,228 | 5,756 | 17,430 | 10,062 | -289 | 10,677 | 14,855 |
| Net profit | 10,081 | 3,967 | 5,444 | 16,541 | 9,533 | -304 | 10,117 | 13,948 |
| Equity | 5,998 | 9,965 | 15,408 | 31,949 | 41,482 | 41,178 | 51,295 | 65,242 |
| Liabilities | 24,570 | 27,308 | 30,308 | 28,948 | 24,383 | 51,640 | 49,973 | 45,574 |
| Non-current assets | 1 | 0 | 0 | 0 | 0 | 21,263 | 17,815 | 14,367 |
| Current assets | 30,567 | 37,273 | 40,773 | 59,376 | 65,619 | 71,104 | 83,044 | 96,449 |
| Total assets | 30,568 | 37,273 | 40,773 | 59,376 | 65,619 | 92,367 | 100,859 | 110,816 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 39,097 | 40,861 | 37,991 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +30.2% | -9.9% | -2.4% | +23.9% | +19.9% | +18.4% | +0.5% | -6.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 33.0% | 10.6% | 13.4% | 27.9% | 14.5% | -0.3% | 10.0% | 12.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 168.1% | 39.8% | 35.3% | 51.8% | 23.0% | -0.7% | 19.7% | 21.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.3% | 4.1% | 5.7% | 14.0% | 6.7% | -0.2% | 6.0% | 8.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.8% | 4.3% | 6.0% | 14.7% | 7.1% | -0.2% | 6.3% | 9.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.1 | 2.7 | 2.0 | 0.9 | 0.6 | 1.3 | 1.0 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 54,314 | 48,923 | 47,725 | 59,139 | 70,901 | 83,916 | 84,376 | 79,144 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
FARMEDA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-20 | 2026-04-21 | 0.06 |
| 2022-11-17 | 2022-11-18 | 4.45 |
| 2022-10-31 | 2022-11-10 | 4.45 |
| 2022-08-23 | 2022-08-24 | 0.55 |
| 2022-07-25 | 2022-08-11 | 0.55 |
FARMEDA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
FARMEDA, UAB (code 302426891) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €158.3K and net profit of €13.9K, corresponding to a profit margin of 8.8%. Revenue declined by 6.2% year on year and was 5.7% lower than two years earlier, but profitability improved steadily across the period. Net profit moved from a small loss of €304 in 2023 to €10.1K in 2024 and €13.9K in 2025, while profit before tax rose to €14.9K in 2025. The balance sheet also strengthened: total assets increased to €110.8K, equity reached €65.2K, and liabilities declined to €45.6K. The equity ratio stood at 58.9% and debt to equity at 0.70, indicating a conservative capital structure. Asset turnover was 1.43x, ROE was 21.4%, and ROA was 12.6%. Revenue per employee was €79.1K, with profit per employee of €7.0K.